The free go-to app for
Philips Healthworks Alumni
4.9 out of 5 stars in the App Store
Astellas C3 Prize Finalist
These tools are used to get a 5 and 10-year overall survival of patients with and without chemotherapy in an adjuvant setting. ONCOassist has created these tools in partnership with some of the world's leading Universities and is the only platform to offer these tools specifically for mobile usage.
With over 20 interactive formulas, ONCOassist is focused on offering oncology hcp’s the information they require instantly at point of care. Notable formulas include BSA, Corrected QT Interval (QTc), and BMI formulas.
With over 14 prognostic scores tailored for a number of specialties, ONCOassist has worked to make the scores intuitive and easy to use. Previously oncology hcp’s were required to look up clinical papers or access online resources to get the prognostic score they require. With a series of questions based on these clinical papers, ONCOassist has cut down a task that took a number of minutes to just a few seconds.
Common Toxicity Criteria AE V4/V5
The Common Terminology Criteria for Adverse Events (CTCAE) formerly called the Common Toxicity Criteria (CTC or NCI-CTC), is a set of criteria for the standardized classification of adverse effects of drugs used in cancer therapy.
AJCC TNM Staging
The AJCC staging system is a classification system developed by the American Joint Committee on Cancer for describing the extent of disease progression in cancer patients. It utilizes in part the TNM scoring system: Tumor size, Lymph Nodes affected, Metastases. ONCOassist has licensed to TNM staging criteria from the AJCC to create an easy to use and interactive functionality. We offer our community access to the 7th and 8th Edition of the staging criteria. criteria.
The Drug info section gives our community access to a comprehensive list of oncology-specific drug information. Derived from the summary of product characteristics (SMPC), we organize the drug information in an easy to navigate structure that allows the user to jump in and out of a specific section quickly.
What our users say
“I love the comprehensive nature of the app – I don’t need to use multiple apps to stage then look for prognosis, discuss adjuvant benefits, calculate BSA, GFR, etc. It also has the CTCAE criteria to grade adverse effects built within it when seeing trial patients. The more you use it, the more you discover and realise how much is contained within it. The other great thing is that the developers are very keen to listen to feedback and I have seen many great changes implemented over the time I’ve been using it and providing feedback.”
“Surprisingly useful. This app is really what was missing for oncologist with interest in technology. Normally I would use up to 3 ups for dealing with the needs of a patient, and now I can find everything in the app. It is important to mention how available the developers are. I hope to contribute to make this app even better. Definitely recommended.”
“ONCOassist allows rapid access to a wide range of evidence-based tools which can inform both the clinician and the patient, and which have the ability to focus the consultation on the most pressing aspects of a patient’s treatment journey. Importantly, at a time when clinicians are increasingly under time pressure, ONCOassist also facilitates easy, rapid access to commonly used clinical algorithms and calculators, thereby promoting both efficient and safe clinical practice, and it seems inevitable that it will increasingly be adopted by busy trainees, both within and outwith oncology.”